F54F11.1

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on ester bonds. Expressed in pharyngeal gland cell.

lipl-8

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on ester bonds. Predicted to be involved in lipid catabolic process.

T02E9.6

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on glycosyl bonds. Predicted to be involved in xylan catabolic process.

Y37H2A.1

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on ester bonds. Is an ortholog of human TATDN2 (TatD DNase domain containing 2).

Y24F12A.1

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on ester bonds. Is an ortholog of human TATDN2 (TatD DNase domain containing 2).

B0432.8

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on ester bonds and metal ion binding activity. Is an ortholog of human TATDN3 (TatD DNase domain containing 3).

ZK287.1

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines and zinc ion binding activity. Predicted to be located in nucleus. Expressed in tail.

lgx-1

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds. Predicted to be involved in carbohydrate metabolic process. Expressed in somatic cell.

C24B5.4

Caenorhabditis elegans

Predicted to enable hydrolase activity, acting on ester bonds and zinc ion binding activity. Predicted to be located in nucleus. Expressed in body wall musculature. Is an ortholog of human C11orf54 (chromosome 11 open reading frame 54).

YDR444W

Saccharomyces cerevisiae

Putative hydrolase acting on ester bonds